Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

PSMA PET

  • You have access
    PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
    Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine March 30, 2023, jnumed.122.265242; DOI: https://doi.org/10.2967/jnumed.122.265242
  • Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
    Open Access
    Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
    Andrei Gafita, Isabel Rauscher, Manuel Weber, Boris Hadaschik, Hui Wang, Wesley R. Armstrong, Robert Tauber, Tristan R. Grogan, Johannes Czernin, Matthew B. Rettig, Ken Herrmann, Jeremie Calais, Wolfgang A. Weber, Matthias R. Benz, Wolfgang P. Fendler and Matthias Eiber
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1651-1658; DOI: https://doi.org/10.2967/jnumed.121.263072
  • Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
    You have access
    Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
    Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen and Henk G. van der Poel
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1531-1536; DOI: https://doi.org/10.2967/jnumed.121.263139
  • Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with <sup>177</sup>Lu-PSMA Therapy: A Multicenter Retrospective Analysis
    You have access
    Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis
    Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1484-1488; DOI: https://doi.org/10.2967/jnumed.121.263441
  • 
    Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
    You have access
    Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
    Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland and Janet H. Pollard
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 746-753; DOI: https://doi.org/10.2967/jnumed.121.262528
  • Factors Predicting Metastatic Disease in <sup>68</sup>Ga-PSMA-11 PET–Positive Osseous Lesions in Prostate Cancer
    You have access
    Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET–Positive Osseous Lesions in Prostate Cancer
    Le Wen Chiu, Courtney Lawhn-Heath, Spencer C. Behr, Roxanna Juarez, Paola M. Perez, Iryna Lobach, Matthew D. Bucknor, Thomas A. Hope and Robert R. Flavell
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1779-1785; DOI: https://doi.org/10.2967/jnumed.119.241174
  • You have access
    Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
    Ida Sonni, Matthias Eiber, Wolfgang P. Fendler, Rejah M. Alano, Sitaram S. Vangala, Amar U. Kishan, Nicholas Nickols, Matthew B. Rettig, Robert E. Reiter, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1153-1160; DOI: https://doi.org/10.2967/jnumed.119.237602
  • You have access
    68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
    Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar-Oromieh, Rahul Aggarwal, Charles J. Ryan, Peter R. Carroll, Eric J. Small and Michael J. Evans
    Journal of Nuclear Medicine January 1, 2017, 58 (1) 81-84; DOI: https://doi.org/10.2967/jnumed.116.181800
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire